Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes

Recent developments suggest that increased glucagon and decreased somatostatin secretion from the pancreas contribute to hyperglycaemia in type-2 diabetes (T2D) patients. There is a huge need to understand changes in glucagon and somatostatin secretion to develop potential anti-diabetic drugs. To fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothegala, Lakshmi, Miranda, Caroline, Singh, Meetu, Krieger, Jean-Philippe, Gandasi, Nikhil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959292/
https://www.ncbi.nlm.nih.gov/pubmed/36834860
http://dx.doi.org/10.3390/ijms24043449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959292/
https://www.ncbi.nlm.nih.gov/pubmed/36834860
http://dx.doi.org/10.3390/ijms24043449

Ejemplares similares